NextCure, Inc. (NXTC) stock
NXTCNasdaqPharmaceutical PreparationsFiscal year ends December 31
$6.40+0.17 (+2.73%)
Close on Nov 13, 2026Market cap $29.30MP/E –Yield 0.00%
NextCure profit margin
Profit margin (net margin) is net income as a percentage of revenue.
NextCure's profit margin for the twelve months ending Dec 31, 2020 was -163.6%. For fiscal 2020 it was -163.6%, against -531.5% the year before.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2020 | Dec 31, 2020 | -163.6% | +368.0 |
| FY2019 | Dec 31, 2019 | -531.5% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q1 FY2020 | Mar 31, 2020 | 43.5% | +497.1 |
| Q4 FY2019 | Dec 31, 2019 | -545.0% | – |
| Q3 FY2019 | Sep 30, 2019 | -532.8% | – |
| Q2 FY2019 | Jun 30, 2019 | -586.4% | – |
| Q1 FY2019 | Mar 31, 2019 | -453.6% | – |
See a number that looks wrong?